Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Gastroenterology · Chronic Pancreatitis

Restoring Balance: Managing Digestion and Blood Sugar

At a Glance

Chronic pancreatitis can reduce digestive enzyme and hormone production, so care may include prescription pancreatic enzymes with meals, nutrition and bone monitoring, regular diabetes screening, and a clear plan for dangerous low blood sugar.

As chronic pancreatitis progresses, the pancreas may lose its ability to perform its two primary jobs: producing digestive enzymes (exocrine function) and producing hormones like insulin (endocrine function). Managing these “insufficiencies” is a cornerstone of long-term care, focused on restoring nutrition and stabilizing blood sugar [1][2].

Exocrine Pancreatic Insufficiency (EPI)

EPI occurs when the pancreas no longer releases enough enzymes to break down food, especially fats. This can lead to malnutrition, weight loss, and debilitating digestive symptoms [1]. Note that not everyone with CP develops EPI right away, and treatment is initiated based on clinical assessment and testing.

Managing EPI with PERT

The standard treatment for EPI is Pancreatic Enzyme Replacement Therapy (PERT). These are prescription capsules containing lipase (to digest fat), protease (for protein), and amylase (for starch).

  • Proper Dosing: Dosing is highly individualized. While guidelines commonly suggest a starting adult dose around 40,000 to 50,000 USP units of lipase with a full meal (and half that for snacks), this is a starting point, not a universal target [1][3]. Your dose depends on the product, meal size, and fat content. Never change your dose without consulting your prescriber or dietitian.
  • The “With Food” Rule: Enzymes must be taken with your meal. Many specialists recommend taking the first capsules with your first bite and spreading the rest throughout the meal so they mix thoroughly with the food [3][4]. Do not chew or crush enteric-coated capsules or beads.
  • Don’t Fear Fat: It is a common mistake to follow an unnecessarily strict, very-low-fat diet to avoid symptoms. Fat is necessary for absorbing essential vitamins. Instead of cutting fat entirely, the goal is to use the correct dose of PERT to digest a healthy, balanced diet. Frequent, smaller meals are often easier for the body to process than three large ones [5][2][6].

Bone Health and Nutrition

Because EPI interferes with the absorption of fat-soluble vitamins (A, D, E, and K), people with chronic pancreatitis can be at a higher risk for bone loss and malnutrition [1][7].

  • Individualized Monitoring: Many guidelines suggest a baseline DXA scan (a specialized X-ray for bone density) and periodic blood tests for vitamins A, D, E, and K [1][8]. However, the frequency of these tests should be customized by your care team based on your EPI severity, nutritional status, age, and fracture risk [9].
  • Safe Supplementation: Routine, high-dose supplementation of fat-soluble vitamins without lab deficits can actually cause harm. Supplementation should always be guided by laboratory results and clinical context [5][10].

Pancreatogenic (Type 3c) Diabetes

When the pancreas scars, it can damage the cells that regulate blood sugar. This is known as Type 3c (pancreatogenic) diabetes [11][12]. It has no single definitive diagnostic test and can sometimes overlap with features of Type 2 diabetes. Because Type 3c can develop silently, you should receive a HbA1c test or a fasting glucose test at least once every year to check for early signs of diabetes [13][14].

Why Type 3c Can Be Difficult to Control

Unlike Type 1 or Type 2 diabetes, Type 3c involves the loss of multiple hormones. It involves a shortage of insulin, but crucially, it can also involve an impaired response of glucagon—the hormone that normally prevents your blood sugar from dropping too low [15][16].

  • Labile Blood Sugar: Because of insulin deficiency, malabsorption, inconsistent eating due to pain, and poor glucagon response, blood sugar can be highly labile (fluctuating).
  • Hypoglycemia Risk: People with advanced Type 3c diabetes, particularly those using insulin or insulin-releasing drugs, face a significant risk of hypoglycemia (low blood sugar) [17][18].
  • Have an Action Plan: You must have a clear hypoglycemia action plan. Know the symptoms (shakiness, sweating, confusion) and know what to do [19]. Crucially, your family or caregivers must know how to get emergency help if you experience confusion, a seizure, or an inability to swallow.

Common questions in this guide

How should I take pancreatic enzymes for chronic pancreatitis?
Pancreatic enzyme replacement therapy, or PERT, works best when taken with food, usually starting with the first bite and, when prescribed, spreading the capsules throughout the meal. Swallow enteric-coated capsules or beads whole; do not chew or crush them. Your prescriber or dietitian should determine the dose based on the product, meal size, and fat content.
What dose of PERT is usually used for chronic pancreatitis?
A common adult starting point is about 40,000 to 50,000 USP units of lipase with a full meal and about half that with a snack. This is not a universal target because the product, meal size, and fat content affect dosing. Do not change the dose without guidance from your prescriber or dietitian.
Should I avoid dietary fat when chronic pancreatitis causes digestive problems?
Usually, the goal is not to eliminate fat because dietary fat supports absorption of essential vitamins. Correctly dosed PERT can help digest a balanced diet, and smaller, more frequent meals may be easier to tolerate. Ask your care team before making major diet changes.
How are nutrition and bone health monitored with pancreatic insufficiency?
Exocrine pancreatic insufficiency can reduce absorption of vitamins A, D, E, and K and increase the risk of malnutrition and bone loss. Your care team may use blood tests and a baseline DXA bone-density scan, with repeat testing based on EPI severity, nutritional status, age, and fracture risk. High-dose vitamin supplements should be guided by laboratory results.
Can chronic pancreatitis lead to type 3c diabetes?
Yes. Scarring from chronic pancreatitis can damage cells that make insulin and glucagon, causing blood sugar to fluctuate and sometimes fall too low. Because this diabetes can develop silently, regular screening with an HbA1c or fasting glucose test, at least annually, can help detect it early.
What should my family do if I become severely low in blood sugar?
Follow the individualized hypoglycemia action plan provided by your diabetes care team. Family or caregivers should know how to get emergency help immediately if you are confused, have a seizure, or cannot swallow.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Idiopathic chronic pancreatitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and fecal elastase test, do I currently need Pancreatic Enzyme Replacement Therapy (PERT)?
  2. 2.If I am on PERT, how should I adjust my dose based on the size and fat content of my meals?
  3. 3.Given my individual risk factors, how often should we schedule a DXA bone density scan and check my fat-soluble vitamin levels?
  4. 4.Do my blood sugar trends suggest that my pancreas is losing its ability to regulate glucose, and how should we monitor this?
  5. 5.What is my specific 'action plan' if I experience symptoms of severe hypoglycemia (low blood sugar)?

References

References (19)
  1. 1

    AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review.

    Whitcomb DC, Buchner AM, Forsmark CE

    Gastroenterology 2023; (165(5)):1292-1301 doi:10.1053/j.gastro.2023.07.007.

    PMID: 37737818
  2. 2

    Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis.

    Duggan SN

    The Proceedings of the Nutrition Society 2017; (76(4)):484-494 doi:10.1017/S0029665117001045.

    PMID: 28735575
  3. 3

    Pancreatic Enzyme Replacement Therapy: A Concise Review.

    Brennan GT, Saif MW

    JOP : Journal of the pancreas 2019; (20(5)):121-125.

    PMID: 31736680
  4. 4

    Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.

    de la Iglesia-García D, Huang W, Szatmary P, et al.

    Gut 2017; (66(8)):1354-1355 doi:10.1136/gutjnl-2016-312529.

    PMID: 27941156
  5. 5

    Nutritional management of chronic pancreatitis: A systematic review and meta-analysis of randomized controlled trials.

    Wiese M, Gärtner S, Doller J, et al.

    Journal of gastroenterology and hepatology 2021; (36(3)):588-600 doi:10.1111/jgh.15230.

    PMID: 32864758
  6. 6

    Optimizing nutrition in chronic pancreatitis.

    Talukdar R, Unnisa M

    Current opinion in gastroenterology 2022; (38(5)):495-500 doi:10.1097/MOG.0000000000000866.

    PMID: 35916323
  7. 7

    Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis.

    Martínez-Moneo E, Stigliano S, Hedström A, et al.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2016; (16(6)):988-994 doi:10.1016/j.pan.2016.09.008.

    PMID: 27681502
  8. 8

    Chronic Pancreatitis and Bone Disease.

    Barkin JA, Barkin JS

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2020; (23(2)):237-243 doi:10.1016/j.jocd.2019.08.004.

    PMID: 31558406
  9. 9

    Fat-soluble vitamin deficiency and exocrine pancreatic insufficiency among adults with chronic pancreatitis: Is routine monitoring necessary for all patients?

    Estes-Doetsch H, Roberts K, Newkirk M, Parker A

    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2024; (39(1)):129-140 doi:10.1002/ncp.11082.

    PMID: 37840401
  10. 10

    Micronutrient deficits in patients with chronic pancreatitis: prevalence, risk factors and pitfalls.

    Jøker-Jensen H, Mathiasen AS, Køhler M, et al.

    European journal of gastroenterology & hepatology 2020; (32(10)):1328-1334 doi:10.1097/MEG.0000000000001866.

    PMID: 32732813
  11. 11

    Diagnosis and risk factors in pancreatogenic diabetes.

    Sharma RK, Singh A, Dawra S

    Advances in clinical chemistry 2026; (131()):177-193 doi:10.1016/bs.acc.2025.10.003.

    PMID: 41708204
  12. 12

    Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.

    Qi L, Wei Q, Ni M, et al.

    Diabetes & metabolism 2022; (48(3)):101316 doi:10.1016/j.diabet.2021.101316.

    PMID: 34929379
  13. 13

    Pancreatogenic Diabetes in Children With Recurrent Acute and Chronic Pancreatitis: Risks, Screening, and Treatment (Mini-Review).

    Bellin MD

    Frontiers in pediatrics 2022; (10()):884668 doi:10.3389/fped.2022.884668.

    PMID: 35558377
  14. 14

    Chronic pancreatitis.

    Beyer G, Habtezion A, Werner J, et al.

    Lancet (London, England) 2020; (396(10249)):499-512 doi:10.1016/S0140-6736(20)31318-0.

    PMID: 32798493
  15. 15

    Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.

    Mumme L, Breuer TGK, Rohrer S, et al.

    Diabetes care 2017; (40(10)):1314-1322 doi:10.2337/dc17-0792.

    PMID: 28751547
  16. 16

    A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes.

    Hart PA, Kudva YC, Yadav D, et al.

    The Journal of clinical endocrinology and metabolism 2023; (108(5)):e120-e128 doi:10.1210/clinem/dgac670.

    PMID: 36404274
  17. 17

    Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 Diabetes.

    Davidsen L, Jensen MH, Kronborg T, et al.

    Journal of diabetes science and technology 2025; 19322968251356239 doi:10.1177/19322968251356239.

    PMID: 40682262
  18. 18

    Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and All-Cause Mortality in Postpancreatitis Diabetes Mellitus Versus Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

    Olesen SS, Viggers R, Drewes AM, et al.

    Diabetes care 2022; (45(6)):1326-1334 doi:10.2337/dc21-2531.

    PMID: 35312752
  19. 19

    Glycemic variability in chronic calcific pancreatitis with diabetes mellitus and its possible determinants.

    Chowdhury AS, Palui R, Pramanik S, Mondal S

    Diabetes & metabolic syndrome 2024; (18(8)):103100 doi:10.1016/j.dsx.2024.103100.

    PMID: 39142092

This page explains how chronic pancreatitis can affect digestion, nutrition, and blood sugar for informational purposes only and does not constitute medical advice. Ask your prescriber, dietitian, or diabetes care team before changing enzymes, supplements, or glucose treatment.